NDC11 63323060701
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0607-01 | 63323-0607 |
| 63323-0607-1 | 63323-0607 |
| 63323-607-01 | 63323-607 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Fresenius Kabi USA, LLC | 21b095d1-5ade-43e9-9114-30fbfb2331c9 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 63323-607-01 63323-607 63323060701 |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Fresenius Kabi USA, LLC | 066f27ec-352c-4051-ba29-248e292690db | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 63323-607 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.